Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome?the individual's genetic code and how their cells express their genes as proteins?by applying molecular biology to medical testing.

Mainly because of their relative simplicity, ease of manipulation and growth in vitro, and importance in medicine, bacteria were instrumental in the development of molecular biology.
Molecular diagnostics are highly effective in diagnosing infectious diseases and performing preventive cancer screening thus helping healthcare professionals to prescribe accurate therapeutic interventions in the early stages of diseases. Increasing prevalence of hospital acquired infections and other communicable infections are anticipated to drive the sector expansion over the forecast period.
The classification of molecular microbiology includes quantitative PCR detection diagnostic kits, pathogenic microorganisms? diagnostic kits and other. The proportion of pathogenic microorganisms? diagnostic kits in 2016 is about 45.8%. PCR was the largest segment in terms of revenue generation, Moreover, the growing availability of diseases-specific; real time PCR kits are further estimated to boost the growth.
Molecular Microbiology is application for human and veterinary. The most of Molecular Microbiology is used for human, and the market share in 2016 is about 92.5%.

According to this study, over the next five years the Molecular Microbiology market will register a 10.2% CAGR in terms of revenue, the global market size will reach USD 8290 million by 2024, from USD 4630 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Molecular Microbiology business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Microbiology market by product type, application, key manufacturers and key regions and countries.

This study considers the Molecular Microbiology value and volume generated from the sales of the following segments-

Segmentation by product type- breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Quantitative PCR Detection Diagnostic Kits
Pathogenic Microorganisms Diagnostic Kits
Segmentation by application- breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Human
Veterinary

This report also splits the market by region- Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report- Breakdown data in in Chapter 3.
Roche
Qiagen
Illumina
Abbott
Hologic
BioMerieux
Danaher (Cepheid)
Myriad Genetics
DAAN Gene
Agilent
Genomic Health
BD
Foundation Medicine

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Molecular Microbiology consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Molecular Microbiology market by identifying its various subsegments.
Focuses on the key global Molecular Microbiology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Molecular Microbiology with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Molecular Microbiology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.